Establishment of Pseudomonas aeruginosa infection: Lessons from a versatile opportunist

Microbes and Infection

Volumn 2, Issue 9, 2000, Pages 1051-1060

  Lyczak, Jeffrey B ^a,b   Cannon, Carolyn L ^b,c   Pier, Gerald B ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Pseudomonas aeruginosa; Toxins; Virulence

Indexed keywords

BACTERIAL ENZYME; BACTERIAL TOXIN; BACTERIUM LIPOPOLYSACCHARIDE; EXOTOXIN; PROTEINASE; VIRULENCE FACTOR;

BACTERIAL VIRULENCE; BACTERIUM PILUS; BURN; CYSTIC FIBROSIS; EYE INFECTION; FLAGELLUM; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; KERATITIS; LUNG INFECTION; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0033847562     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)01259-4     Document Type: Review

References (100)

1. Agricultural plants and soil as a reservoir for Pseudomonas aeruginosa
2. Rodent zoonoses in North Queensland: The occurrence and distribution of zoonotic infections in North Queensland rodents
3. Ubiquity of plasmids in coding for toluene and xylene metabolism in soil bacteria: Evidence for the existence of new TOL plasmids
4. Pseudomonas infections in patients with AIDS and AIDS-related complex
5. Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection
6. Two neutropenic patients with multiple resistant Pseudomonas aeruginosa septicaemia treated with ciprofloxacin
7. Endogenous and exogenous infection with Pseudomonas aeruginosa in a burns unit
8. The effect of endogenous skin bacteria on burn wound infection
9. Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit
10. Common virulence factors for bacterial pathogenicity in plants and animals
11. Role of pili in the pathogenesis of Pseudomonas aeruginosa burn infection
12. Assessment of protease (elastase) as a Pseudomonas aeruginosa virulence factor in experimental mouse burn infection
13. Degradation of basement membranes by Pseudomonas aeruginosa elastase
14. Inhibition of human monocyte chemotaxis and chemiluminescence by Pseudomonas aeruginosa elastase
15. Contribution of the regulatory gene lasR to the pathogenesis of Pseudomonas aeruginosa infection of burned mice
16. Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections
17. Identification of a new phospholipase C activity by analysis of an insertional mutation in the hemolytic phospholipase C structural gene of Pseudomonas aeruginosa
18. Surface expression of ferripyochelin-binding protein is required for virulence of Pseudomonas aeruginosa
19. Avirulence of a Pseudomonas aeruginosa algC mutant in a burned-mouse model of infection
20. Contribution of exoenzyme S to the virulence of Pseudomonas aeruginosa
21. Infection control in a Third World burn facility
22. Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa infection in a murine burn wound model
23. Fc and complement receptor integrity of polymorphonuclear (PMN) cells following thermal injury
24. Failure of local immunity. A potential cause of burn wound sepsis
25. Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon
26. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa
27. Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury
28. Improved growth and clinical, nutritional, and respiratory changes in response to nutritional therapy in cystic fibrosis
29. The changing epidemiology of cystic fibrosis
30. Treatment of Staphylococcus aureus in cystic fibrosis
31. Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis
32. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis
33. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients
34. An atypical Pseudomonas aeruginosa associated with cystic fibrosis of the pancreas
35. A new polysaccharide resembling alginic acid isolated from pseudomonads
36. Phenotypic differences among clinically isolated mucoid Pseudomonas aeruginosa strains
37. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis
38. Selection of nonmucoid derivatives of mucoid Pseudomonas aeruginosa is strongly influenced by the level of iron in the culture medium
39. Role of energy metabolism in conversion of nonmucoid Pseudomonas aeruginosa to the mucoid phenotype
40. Alginate synthesis in mucoid Pseudomonas aeruginosa: A chromosomal locus involved in control
41. Cloning of genes controlling alginate biosynthesis from a mucoid cystic fibrosis isolate of Pseudomonas aeruginosa
42. Genetic analysis of the alginate biosynthetic gene cluster of Pseudomonas aeruginosa shows evidence of an operonic structure
43. DNA sequence and expression analysis of algP and algQ, components of the multi-gene system transcriptionally regulating mucoidy in Pseudomonas aeruginosa: AlgP contains multiple direct repeats
44. Transcriptional analysis of the Pseudomonas aeruginosa genes algR, algB, and algD reveals a hierarchy of alginate gene expression which is modulated by algT
45. Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation
46. Analysis of promoters controlled by the putative sigma factor AlgU regulating conversion to mucoidy in Pseudomonas aeruginosa: Relationship to sigma E and stress response
47. A mutation in algN permits trans activation of alginate production by algT in Pseudomonas species
48. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: A mechanism for virulence activation in the cystic fibrosis lung
49. In vitro phosphorylation of AlgR, a regulator of mucoidy in Pseudomonas aeruginosa, by a histidine protein kinase and effects of small phospho- donor molecules
50. Identification of the histidine protein kinase KinB in Pseudomonas aeruginosa and its phosphorylation of the alginate regulator algB
51. Phosphorylation-independent activity of the response regulators AlgB and AlgR in promoting alginate biosynthesis in mucoid Pseudomonas aeruginosa
52. Identification of the algZ gene upstream of the response regulator algR and its participation in control of alginate production in Pseudomonas aeruginosa
53. Further studies on the pathogenesis of fibrocystic disease of the pancreas
54. The ductular cell in pancreatic cystic fibrosis
55. The genesis of cystic fibrosis lung disease
56. Effect of anion transport inhibition on mucus secretion by airway submucosal glands
57. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis
58. Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects
59. How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis
60. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections
61. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung
62. Bacterial precipitins in serum of patients with cystic fibrosis
63. Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis
64. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis
65. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation
66. Early pulmonary inflammation in infants with cystic fibrosis
67. Altered respiratory epithelial cell cytokine production in cystic fibrosis
68. Cornea and sclera
69. Corneal ulcers associated with contact lens wear
70. Corneal ulcers associated with extended-wear soft contact lenses
71. Influence of malnutrition on the concentration of IgA, lysozyme, amylase and aminopeptidase in children's tears
72. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis
73. Modulation of Pseudomonas aeruginosa adherence to the corneal surface by mucus
74. Detection of mucus glycoconjugates in human conjunctiva by using the lectin-colloidal gold technique in TEM. III. A quantitative study in asymptomatic contact lens wearers
75. Differences in adhesion of Pseudomonas aeruginosa to mucin glycopeptides from sputa of patients with cystic fibrosis and chronic bronchitis
76. Pseudomonas eye infections in cyclophosphamide-treated mice
77. Effect of C3 depletion on experimental Pseudomonas aeruginosa ocular infection: Histopathological analysis
78. Corneal collagenolytic activity in rabbit polymorphonuclear leukocytes
79. Pseudomonas aeruginosa: Clinical manifestations of infection and current therapy
80. Inhibition of yeast phagocytosis in macrophage cultures treated with slime polysaccharide purified from Pseudomonas aeruginosa
81. Corneal rings with gram-negative bacteria
82. Cystic fibrosis transmembrane conductance regulator-mediated corneal epithelial cell ingestion of Pseudomonas aeruginosa is a key component in the pathogenesis of experimental murine keratitis
83. Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro
84. Cloning, nucleotide sequence, and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa
85. Cloning and expression of a gene segment encoding the enzymatic moiety of Pseudomonas aeruginosa exotoxin A
86. Pathogenesis of corneal damage from Pseudomonas exotoxin A
87. Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence
88. Protease-deficient mutants of Pseudomonas aeruginosa: Pleiotropic changes in activity of other extracellular enzymes
89. Experimental bacterial keratitis in neutropenic guinea pigs: Polymorphonuclear leukocytes in corneal host defense
90. Rabbit corneal damage produced by Pseudomonas aeruginosa infection
91. Experimental Pseudomonas keratitis in the rabbit: Bacteriologic, clinical, and microscopic observations
92. Contribution of proteases and LasR to the virulence of Pseudomonas aeruginosa during corneal infections
93. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence
94. Pseudomonas deficient in protease IV has significantly reduced corneal virulence
95. Pili and lipopolysaccharide of Pseudomonas aeruginosa bind to the glycolipid asialo GM1
96. Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection
97. Pili binding to asialo-GM1 on epithelial cells can mediate cytotoxicity or bacterial internalization by Pseudomonas aeruginosa
98. Pseudomonas aeruginosa infection of the cornea and asialo GM1
99. Evidence for asialo GM1 as a corneal glycolipid receptor for Pseudomonas aeruginosa adhesion